Related Experiment Video
Updated: Feb 10, 2026

Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
Published on: February 24, 2023
Bayesian network analyses of resistance pathways against efavirenz and nevirapine
Koen Deforche1, Ricardo J Camacho, Zehave Grossman
1Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium.
Objective:
To clarify the role of novel mutations selected by treatment with efavirenz or nevirapine, and investigate the influence of HIV-1 subtype on nonnucleoside reverse transcriptase inhibitor (nNRTI) resistance pathways.
Design:
By finding direct dependencies between treatment-selected mutations, the involvement of these mutations as minor or major resistance mutations against efavirenz, nevirapine, or coadministrated nucleoside analogue reverse transcriptase inhibitors (NRTIs) is hypothesized. In addition, direct dependencies were investigated between treatment-selected mutations and polymorphisms, some of which are linked with subtype, and between NRTI and nNRTI resistance pathways.
Methods:
Sequences from a large collaborative database of various subtypes were jointly analyzed to detect mutations selected by treatment. Using Bayesian network learning, direct dependencies were investigated between treatment-selected mutations, NRTI and nNRTI treatment history, and known NRTI resistance mutations.
Results:
Several novel minor resistance mutations were found: 28K and 196R (for resistance against efavirenz), 101H and 138Q (nevirapine), and 31L (lamivudine). Robust interactions between NRTI mutations (65R, 74V, 75I/M, and 184V) and nNRTI resistance mutations (100I, 181C, 190E and 230L) may affect resistance development to particular treatment combinations. For example, an interaction between 65R and 181C predicts that the nevirapine and tenofovir and lamivudine/emtricitabine combination should be more prone to failure than efavirenz and tenofovir and lamivudine/emtricitabine.
Conclusion:
Bayesian networks were helpful in untangling the selection of mutations by NRTI versus nNRTI treatment, and in discovering interactions between resistance mutations within and between these two classes of inhibitors.
Insights
This study identified novel mutations conferring resistance to nonnucleoside reverse transcriptase inhibitors (NNRTIs) like efavirenz and nevirapine. It also revealed interactions between NRTI and NNRTI resistance mutations, impacting HIV treatment efficacy.
Area of Science:
- Virology
- Molecular Biology
- Pharmacology
Background:
- Nonnucleoside reverse transcriptase inhibitors (NNRTIs) are crucial in HIV-1 treatment regimens.
- Understanding drug resistance mutations is vital for optimizing antiretroviral therapy.
- HIV-1 subtypes can influence the development of drug resistance pathways.
Purpose of the Study:
- To identify novel mutations selected by efavirenz and nevirapine treatment.
- To investigate the impact of HIV-1 subtype on NNRTI resistance.
- To explore interactions between nucleoside reverse transcriptase inhibitor (NRTI) and NNRTI resistance mutations.
Main Methods:
- Analysis of a large, multi-subtype HIV-1 sequence database.
- Utilizing Bayesian network learning to identify dependencies between mutations.
- Investigating direct dependencies between treatment-selected mutations, NRTI/NNRTI history, and known resistance mutations.
Main Results:
- Discovery of novel minor resistance mutations: 28K, 196R (efavirenz); 101H, 138Q (nevirapine); 31L (lamivudine).
- Identification of robust interactions between specific NRTI (e.g., 65R, 184V) and NNRTI (e.g., 100I, 181C) resistance mutations.
- Demonstration that certain mutation combinations (e.g., 65R and 181C) predict differential treatment failure rates.
Conclusions:
- Bayesian networks effectively untangled mutation selection by NRTI vs. NNRTI treatments.
- Interactions between resistance mutations within and across drug classes were elucidated.
- Findings aid in predicting treatment outcomes and guiding future HIV therapy strategies.
Related Concept Videos
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Network Covalent Solids
To break or to melt a covalent network solid, covalent bonds must be broken. Because covalent bonds are relatively strong, covalent network solids are typically...
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Resistivity
Resistance
Equivalent Resistance

